| Descriptor English: | Emtricitabine, Rilpivirine, Tenofovir Drug Combination | ||||
| Descriptor Spanish: | 
                                Combinación Emtricitabina, Rilpivirina y Tenofovir                                        
                                        
                                                                                                                            
                                            
  | ||||
| Descriptor Portuguese: | Combinação Emtricitabina, Rilpivirina e Tenofovir | ||||
| Descriptor French: | Association d'emtricitabine, de rilpivirine et de ténofovir | ||||
| Entry term(s): | 
                                    Combination, Emtricitabine-Rilpivirine-Tenofovir Drug Complera Drug Combination, Emtricitabine-Rilpivirine-Tenofovir Emtricitabine Rilpivirine Tenofovir Drug Combination Emtricitabine-Rilpivirine-Tenofovir Drug Combination  | 
                                            ||||
| Tree number(s): | 
                                        D02.626.809.500 D02.705.429.906.500 D03.383.742.680.245.500.600.500 D03.383.742.755.500 D03.633.100.759.138.881.500 D26.310.407  | 
                                ||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000068678 | ||||
| Scope note: | A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir disoproxil fumarate. It is used to treat HIV INFECTIONS. | 
                                    ||||
| Allowable Qualifiers: | 
                                                                        AA                                                            analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine  | 
                                            ||||
| Pharm Action: | 
                                                                                                    Antiviral Agents Reverse Transcriptase Inhibitors Anti-HIV Agents  | 
                                    ||||
| Public MeSH Note: | 2016; EMTRICITABINE, RILPIVIRINE, TENOFOVIR DRUG COMBINATION was indexed under NITRILES; PYRIMIDINES; ORGANOPHOSPHONATES; ADENINE; and DEOXYCYTIDINE 2012-2015 | 
                                                ||||
| History Note: | 2016 (2012) | 
                                                ||||
| DeCS ID: | 55898 | ||||
| Unique ID: | D000068678 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 2016/01/01 | ||||
| Date of Entry: | 2015/07/01 | ||||
| Revision Date: | 2016/05/31 | 
- 
                                    
- 
                                        CHEMICALS AND DRUGS
 
Organic Chemicals [D02]Organic Chemicals - 
                                    
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals - 
                                    
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds - 
                                    
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds - 
                                    
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds - 
                                    
CHEMICALS AND DRUGS
Pharmaceutical Preparations [D26]Pharmaceutical Preparations 
| 
                                                             | 
                                
                        
                                                                    
                        Emtricitabine, Rilpivirine, Tenofovir Drug Combination                                            
                                        - Preferred                                        
                                                                
                                
                        
                        
                        
                                                                    
                        Complera                                            
                                        - Narrower                                        
                                                                
                                
                        
                        
                    
                    
                
                | Concept UI | 
                                        
                                        M000603524 | 
                                
| Scope note | A pharmaceutical preparation that contains emtricitabine, rilpivirine and tenofovir disoproxil fumarate. It is used to treat HIV INFECTIONS. | 
| Preferred term | Emtricitabine, Rilpivirine, Tenofovir Drug Combination | 
| Entry term(s) | 
                                        
                                                                                            Combination, Emtricitabine-Rilpivirine-Tenofovir Drug                                                 Drug Combination, Emtricitabine-Rilpivirine-Tenofovir Emtricitabine Rilpivirine Tenofovir Drug Combination Emtricitabine-Rilpivirine-Tenofovir Drug Combination  | 
                                
| Concept UI | 
                                        
                                        M0573815 | 
                                
| Preferred term | Complera | 
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey